Paquette M, Roy D, Talajic M, Newman D, Couturier A, Yang C, Dorian P
St. Michael's Hospital, Toronto, Ontario, Canada.
Am J Cardiol. 2000 Oct 1;86(7):764-8. doi: 10.1016/s0002-9149(00)01077-8.
Patients with atrial fibrillation (AF) report impaired health-related quality of life (QOL). Differences between men and women with AF have not been described and personality attributes such as somatization (tendency to amplify benign bodily sensations) may mediate potential gender differences in QOL. Patients with AF (n = 264, 59% men) who participated in the Canadian Trial of Atrial Fibrillation (n = 403) completed validated QOL questionnaires at baseline, 3 months, and 12 months after antiarrhythmic drug treatment. Women were significantly older than men and a greater proportion had hypertension, but other cardiac variables did not differ between women and men. At baseline, after controlling for significant clinical and demographic factors, women reported worse physical health (p = 0.002) and functional capacity (p < 0.001), but not mental health or general well-being. Women also had more frequent and severe cardiac symptoms than men (both p < 0.001). Physical health improved significantly from baseline to 3 months for women (p = 0.002), but not for men (p = 0.066). Conversely, mental health improved for men (p = 0.007), but not for women. Cardiac symptom frequency and severity improved over time for women and men (all p < 0.001). Tendency to somatize predicted poor QOL, and women had higher scores than men (p = 0.023). However, after controlling for somatization, women still had worse physical function, functional capacity, and symptom burden than men. Independent of cardiac disease severity and age, women with AF had significantly more impaired QOL than men, specifically on domains related to physical rather than emotional functioning. Personality attributes may have a role in influencing QOL outcomes.
心房颤动(AF)患者报告其健康相关生活质量(QOL)受损。AF患者中男性和女性的差异尚未得到描述,而诸如躯体化(放大良性身体感觉的倾向)等人格特质可能介导QOL方面潜在的性别差异。参与加拿大心房颤动试验(n = 403)的AF患者(n = 264,59%为男性)在抗心律失常药物治疗的基线、3个月和12个月时完成了经过验证的QOL问卷。女性比男性年龄显著更大,且有更高比例的女性患有高血压,但女性和男性之间的其他心脏变量并无差异。在基线时,在控制了显著的临床和人口统计学因素后,女性报告的身体健康状况更差(p = 0.002)和功能能力更差(p < 0.001),但心理健康或总体幸福感并无差异。女性的心脏症状也比男性更频繁和严重(均p < 0.001)。从基线到3个月,女性的身体健康状况显著改善(p = 0.002),而男性则未改善(p = 0.066)。相反,男性的心理健康状况有所改善(p = 0.007),而女性则未改善。随着时间推移,女性和男性的心脏症状频率和严重程度均有所改善(均p < 0.001)。躯体化倾向预示着QOL较差,且女性得分高于男性(p = 0.023)。然而,在控制了躯体化因素后,女性的身体功能、功能能力和症状负担仍比男性更差。独立于心脏病严重程度和年龄,AF女性的QOL受损程度显著高于男性,特别是在与身体功能而非情感功能相关的领域。人格特质可能在影响QOL结果方面发挥作用。